Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria.
Velkov, Tony; Gallardo-Godoy, Alejandra; Swarbrick, James D; Blaskovich, Mark A T; Elliott, Alysha G; Han, Meiling; Thompson, Philip E; Roberts, Kade D; Huang, Johnny X; Becker, Bernd; Butler, Mark S; Lash, Lawrence H; Henriques, Sónia Troeira; Nation, Roger L; Sivanesan, Sivashangarie; Sani, Marc-Antoine; Separovic, Frances; Mertens, Haydyn; Bulach, Dieter; Seemann, Torsten; Owen, Jeremy; Li, Jian; Cooper, Matthew A.
Cell Chem Biol
; 25(4): 380-391.e5, 2018 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-29396290
Characterization of the Polymyxin D Synthetase Biosynthetic Cluster and Product Profile of Paenibacillus polymyxa ATCC 10401.
Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.
Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
Key residues in octyl-tridecaptin A1 analogues linked to stable secondary structures in the membrane.
Biosynthetic Studies of Telomycin Reveal New Lipopeptides with Enhanced Activity.
Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.
Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.
Biochemical, structural, and genetic characterization of tridecaptin A1, an antagonist of Campylobacter jejuni.